Vidara  markets Actimmune, a drug that  is used to treat severe, malignant osteopetrosis.

Dublin-based pharmaceutical company Vidara Therapeutics has been acquired by US drug giant Horizon Pharma in a deal worth $660 million (€474 mi(...)